pharmaCline's Diabecline Antibiotic Receives 2012 American Business Award
Sioux Falls, SD, September 21, 2012 --(PR.com)-- pharmaCline® has received the prestigious Silver Stevie Award for the Best New Health & Pharmaceutical Product of the Year. This award recognized the importance of pharmaCline’s Diabecline® first aid antibiotic. The Stevie Awards ceremony was held Monday evening, September 17, in San Francisco’s Financial District.
This powerful Diabecline® first aid antibiotic prevents infection from a wide variety of bacteria - including the dangerous resistant forms of bacteria. While currently available as an over-the-counter product, the core technology is also being applied to prescription pharmaceutical formulations that will be introduced soon.
“We are honored to receive this award,” said pharmaCline CEO Steve Keough, “and we thank those who recognized this vital healthcare product. Our technology brings new hope to patients and a greater confidence to caregivers in their efforts to prevent serious infections.”
pharmaCline’s technology restores the effective use of old and well known classes of active pharmaceuticals. The Company has created a life extension program for numerous essential drugs. “Our pipeline formulations will add decades of use to well known pharmaceuticals,” added Keough.
pharmaCline is a privately owned South Dakota pharmaceutical company that has received other awards and recognition for its breakthrough innovations. The Company is currently in a private placement round and welcomes strategic partner engagement to enhance the health and productivity of patients worldwide.
pharmaCline products and information are available at http://www.pharmacline.com.
For additional information about The American Business Awards visit http://www.stevieawards.com/pubs/about/69_182_877.cfm.
Contact Information:
Lana McCoy, Executive Marketing Coordinator
Email: lmccoy@pharmacline.com
Phone: 605-271-2086
2329 N. Career Avenue, Suite 243
Sioux Falls, SD 57107
www.pharmacline.com
This powerful Diabecline® first aid antibiotic prevents infection from a wide variety of bacteria - including the dangerous resistant forms of bacteria. While currently available as an over-the-counter product, the core technology is also being applied to prescription pharmaceutical formulations that will be introduced soon.
“We are honored to receive this award,” said pharmaCline CEO Steve Keough, “and we thank those who recognized this vital healthcare product. Our technology brings new hope to patients and a greater confidence to caregivers in their efforts to prevent serious infections.”
pharmaCline’s technology restores the effective use of old and well known classes of active pharmaceuticals. The Company has created a life extension program for numerous essential drugs. “Our pipeline formulations will add decades of use to well known pharmaceuticals,” added Keough.
pharmaCline is a privately owned South Dakota pharmaceutical company that has received other awards and recognition for its breakthrough innovations. The Company is currently in a private placement round and welcomes strategic partner engagement to enhance the health and productivity of patients worldwide.
pharmaCline products and information are available at http://www.pharmacline.com.
For additional information about The American Business Awards visit http://www.stevieawards.com/pubs/about/69_182_877.cfm.
Contact Information:
Lana McCoy, Executive Marketing Coordinator
Email: lmccoy@pharmacline.com
Phone: 605-271-2086
2329 N. Career Avenue, Suite 243
Sioux Falls, SD 57107
www.pharmacline.com
Contact
pharmaCline
Lana McCoy
605-271-7983
www.pharmacline.com
Lana McCoy
605-271-7983
www.pharmacline.com
Contact
Categories